Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

Journal Article Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants Get access Katarzyna Nabrdalik, Katarzyna Nabrdalik Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UKDepartment of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland Search for other works by this author on: Oxford Academic Google Scholar Hanna Kwiendacz, Hanna Kwiendacz Department of Internal Medicine, Diabetology and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland Search for other works by this author on: Oxford Academic Google Scholar Gregory Y H Lip Gregory Y H Lip Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UKDanish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Corresponding author. Email: gregory.lip@liverpool.ac.uk Search for other works by this author on: Oxford Academic Google Scholar European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 435–436, https://doi.org/10.1093/ehjcvp/pvad042 Published: 24 June 2023 Article history Received: 06 June 2023 Accepted: 12 June 2023 Corrected and typeset: 24 June 2023 Published: 24 June 2023